Meiji Yasuda Asset Management CO Ltd. Biomarin Pharmaceutical Inc Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.03 Billion
- Q3 2025
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 9,510 shares of BMRN stock, worth $520,482. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,510
Previous 9,796
2.92%
Holding current value
$520,482
Previous $538,000
4.28%
% of portfolio
0.03%
Previous 0.03%
Shares
27 transactions
Others Institutions Holding BMRN
# of Institutions
667Shares Held
182MCall Options Held
1.48MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...